Drug Maker Will Soon Hold Patent On THC, CBD As Cancer Cures
GW Pharmaceuticals, a drug company that specializes in cannabis-based pharmaceuticals, has received early approval on a patent covering the use of marijuana chemicals for treating brain cancer. GW Pharmaceuticals announced Wednesday that it has been issued a Notice of Allowance from the U.S. Patent Office for a patent application involving the use of THC and CBD, the two main chemicals in marijuana, for treating gliomas. Once a patent application is deemed a genuine invention, the Patent Office sends a Notice of Allowance [...]
